These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37107125)
21. Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients. Bienvenu AL; Pradat P; Plesa A; Leclerc V; Piriou V; Fellahi JL; Argaud L; Rimmelé T; Menotti J; Aubrun F; Richard JC; Gagnieu MC; Parant F; Chidiac C; Leboucher G; Tod M; Goutelle S PLoS One; 2021; 16(11):e0260656. PubMed ID: 34818379 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of procalcitonin and CRP in critically ill patients admitted with suspected sepsis. Joen JS; Ji SM J Dent Anesth Pain Med; 2015 Sep; 15(3):135-140. PubMed ID: 28879270 [TBL] [Abstract][Full Text] [Related]
23. Association of procalcitonin with voriconazole concentrations: a retrospective cohort study. Zhou JX; Xiong CL; Chang ZS; Yin YC; Su KP; Zhang JH; Wu JC; Sun B BMC Infect Dis; 2024 Sep; 24(1):952. PubMed ID: 39256640 [TBL] [Abstract][Full Text] [Related]
24. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia. Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379 [TBL] [Abstract][Full Text] [Related]
25. Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study. Ronda M; Llop-Talaveron JM; Fuset M; Leiva E; Shaw E; Gumucio-Sanguino VD; Diez Y; Colom H; Rigo-Bonnin R; Puig-Asensio M; Carratalà J; Padullés A Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508196 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina. Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043 [TBL] [Abstract][Full Text] [Related]
27. Lower Prealbumin and Higher CRP Increase the Risk of Voriconazole Overexposure and Adverse Reactions. Lin L; Fu X; Hong M Cureus; 2023 Sep; 15(9):e46107. PubMed ID: 37900477 [TBL] [Abstract][Full Text] [Related]
29. [Predictive value of serum procalcitonin and hypersensitive C-reactive protein levels in patients with acute cerebral infarction complicated with infection]. Wang H Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):962-966. PubMed ID: 31537220 [TBL] [Abstract][Full Text] [Related]
30. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients]. Ma J; Wang S; Chen D; Duan J; Li C; Li G Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557 [TBL] [Abstract][Full Text] [Related]
32. Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data. Casalini G; Giacomelli A; Galimberti L; Colombo R; Ballone E; Pozza G; Zacheo M; Galimberti M; Oreni L; Carsana L; Longo M; Gismondo MR; Tonello C; Nebuloni M; Antinori S J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135619 [TBL] [Abstract][Full Text] [Related]
33. Voriconazole metabolism is influenced by severe inflammation: a prospective study. Veringa A; Ter Avest M; Span LF; van den Heuvel ER; Touw DJ; Zijlstra JG; Kosterink JG; van der Werf TS; Alffenaar JC J Antimicrob Chemother; 2017 Jan; 72(1):261-267. PubMed ID: 27601292 [TBL] [Abstract][Full Text] [Related]
34. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M; Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases. Shen K; Gu Y; Wang Y; Lu Y; Ni Y; Zhong H; Shi Y; Su X Ther Adv Drug Saf; 2022; 13():20420986221127503. PubMed ID: 36225945 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child-Pugh class B and C cirrhosis: A multicenter study. Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y Int J Infect Dis; 2018 Jul; 72():49-54. PubMed ID: 29793038 [TBL] [Abstract][Full Text] [Related]
37. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies. Pardo E; Lemiale V; Mokart D; Stoclin A; Moreau AS; Kerhuel L; Calvet L; Valade S; De Jong A; Darmon M; Azoulay E Intensive Care Med; 2019 Dec; 45(12):1732-1741. PubMed ID: 31599334 [TBL] [Abstract][Full Text] [Related]
38. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Enguix A; Rey C; Concha A; Medina A; Coto D; Diéguez MA Intensive Care Med; 2001 Jan; 27(1):211-5. PubMed ID: 11280637 [TBL] [Abstract][Full Text] [Related]
39. Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients. Liang Z; Yu M; Liu Z; Liu F; Jia C; Xiong L; Dai Q; Qin S; Cheng L; Sun F Front Pharmacol; 2022; 13():835871. PubMed ID: 35462904 [No Abstract] [Full Text] [Related]
40. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M; J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]